Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 296 entries
View as:

Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT00151775 Org: User:
Start: 05/31/05 End: 09/30/08 Due: 09/30/09

Effect of Tivantinib on the QTC Interval in Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01699061 Org: User:
Start: 07/31/12 End: 05/31/13 Due: 05/31/14

Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00923091 Org: User:
Start: 06/30/09 End: 03/31/11 Due: 03/31/12

A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation

Phase: N/A Priority: Normal
NCT ID: NCT02047565 Org: User:
Start: 10/31/13 End: 05/31/14 Due: 05/31/15

Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06557967 Org: User:
Start: 03/01/24 End: 09/30/24 Due: 09/30/25

Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00945191 Org: User:
Start: 10/06/09 End: 08/23/11 Due: 08/23/12

A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

Phase: N/A Priority: Normal
NCT ID: NCT06617390 Org: User:
Start: 08/15/24 End: 06/30/25 Due: 06/30/26

A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01468467 Org: User:
Start: 04/30/12 End: 03/31/15 Due: 03/31/16

Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT02076451 Org: User:
Start: 02/28/14 End: 12/31/15 Due: 12/31/16

A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05769764 Org: User:
Start: 12/19/22 End: 04/06/23 Due: 04/06/24

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00412932 Org: User:
Start: 12/31/06 End: 04/30/08 Due: 04/30/09

Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02266940 Org: User:
Start: 11/30/14 End: 01/31/15 Due: 01/31/16

DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT03110354 Org: User:
Start: 04/05/17 End: 03/09/21 Due: 03/09/22

Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)

Phase: N/A Priority: Normal
NCT ID: NCT00320827 Org: User:
Start: - End: - Due: -

A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06686602 Org: User:
Start: 07/09/24 End: 03/18/25 Due: 03/18/26

Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)

Phase: N/A Priority: Normal
NCT ID: NCT01502631 Org: User:
Start: 08/08/12 End: 09/21/14 Due: 09/21/15

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05338970 Org: User:
Start: 07/08/22 End: 06/30/26 Due: 06/30/27

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07022483 Org: User:
Start: 08/25/25 End: 03/23/32 Due: 03/23/33

Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan

Phase: N/A Priority: Normal
NCT ID: NCT06833268 Org: User:
Start: 01/20/25 End: 06/16/25 Due: 06/16/26

Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children

Phase: N/A Priority: Normal
NCT ID: NCT00781521 Org: User:
Start: 11/30/02 End: 04/30/03 Due: 04/30/04

Study of DS-7080a for the Treatment of Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT02530918 Org: User:
Start: 07/31/15 End: 01/02/18 Due: 01/02/19

A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00398216 Org: User:
Start: 05/31/06 End: 06/30/07 Due: 06/30/08

Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project

Phase: N/A Priority: Normal
NCT ID: NCT02948088 Org: User:
Start: 11/18/16 End: 03/11/21 Due: 03/11/22

Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03793478 Org: User:
Start: 08/15/18 End: 05/01/27 Due: 05/01/28

DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE)

Phase: N/A Priority: Normal
NCT ID: NCT03316729 Org: User:
Start: 01/31/18 End: 02/29/20 Due: 02/28/21